Third quarter 2026 earnings call, October 29, 2026

Linde used its third quarter call to concede that the Lincare home healthcare business has become a drag large enough to warrant structural change. The company recorded a $425 million restructuring charge, roughly half of it severance, concentrated in lower-growth regions. The balance relates mainly to portfolio and asset actions at Lincare in the U.S. CEO Sanjiv Lamba opened the call by noting that results three months ago "were not up to the expectation of our owners" and that "that message was received loud and clear." Headline numbers were records, with sales of $9.4 billion, operating profit of $2.8 billion and EPS of $4.59, up 9%. But the operating margin excluding cost pass-through was flat, and management guided the fourth quarter conservatively.

Lincare Leaves the Regional Segments and Could Be Sold

Linde has moved Lincare into the Global Other segment and now has it reporting directly to CFO Matt White. Management framed the move as an accounting consequence of a change in executive oversight, tied to the Chief Operating Decision Maker designation, but it carries strategic weight. White pointed to precedent in the GIST business, which was also shifted into Other with different oversight and was later sold. He was careful not to promise an exit: "We've said we will continue to evaluate strategic options, but we can't assure there will be a strategic option to be had. And so we have to improve this business."

The financial cost is now explicit. Lincare is subtracting about 2% from year-to-date EPS growth, and White said eliminating that headwind "will support the return to double-digit EPS growth for the global organization." Asked about the math, he put the drag at a "very strong 1 to a weak 2" percent for the full year. Lamba said sales at the remaining business will lag the market as the portfolio is trimmed, and that healthcare growth excluding Lincare is mid-single digit versus 2% reported. Lincare remains free cash flow positive. White said depreciation and capex roughly offset, so EBIT is a rough proxy for free cash flow, though working capital is seasonal given the reset of healthcare plan deductibles. Removing Lincare takes about $2.3 billion of annualized sales out of the Americas segment.

The severance savings follow Linde's usual pattern. Cash paybacks are 1 to 2 years, with this program toward the longer end. Savings begin in the fourth quarter, with full run rate in the second half of 2027. White said the benefit will be incremental to the normal productivity embedded in Linde's earnings algorithm, which he described as an ongoing cultural expectation, versus the "episodic" top-down nature of restructuring.

Guidance Embeds Little Credit for the Actions

Fourth quarter EPS guidance of $4.40 to $4.50 implies 5% to 7% growth, a deceleration from the 9% just delivered. The full-year range of $17.82 to $17.92 simply rolls the quarter into year-to-date results. White bridged the sequential decline of about 3% at the midpoint as follows: 1% from a stronger dollar, 1% from a third-quarter equity income spike tied to a customer contract true-up that will not recur, and a final 1% reflecting seasonality and a guarded stance. "We're not yet embedding any meaningful change to Q4 profit," he said, adding that the goal is to beat the range. No economic improvement is assumed, including at Lincare. 2027 guidance will come in February.

Pricing Is Doing More of the Work, With Americas Flattered by Recovery and Optics

Price rose 3% in the quarter, and the Americas reached about 6%. White attributed roughly 2 points to recovery of prior and current cost inflation in power and distribution, mainly in merchant and packaged gases, leaving an underlying run rate near 4%. The recovery is dilutive to Americas margins, which printed at 35%, though net positive to operating profit. The removal of Lincare from the segment's denominator also makes recovery look larger. Management does not expect these costs to persist into the fourth quarter but is prepared for further measures. White noted that merchant and packaged recovery typically lags 3 to 6 months, while on-site is passed through in the month.

Management signaled pricing could broaden. In EMEA, energy spikes have so far been handled through surcharges rather than permanent price, but White said that "may start to accelerate." In APAC, about half of the pricing is helium. Lamba said China is seeing positive inflation for the first time in several quarters. This partly explains cost of goods sold rising 13% year over year, which analyst Duffy Fischer of Goldman Sachs flagged as high. White cited currency, 1% of cost pass-through, a mix shift toward higher variable cost hydrogen, acquisitions and recovery.

End Markets: Electronics and U.S. Gulf Coast Lead, Europe Has No Catalyst

Electronics grew 15%, driven by organic growth in APAC and the U.S. and excluding the 50%-owned Taiwanese joint venture, which is growing at similar rates. About $2 billion of electronics projects are under construction in the U.S., Korea and China, supporting what Lamba expects to be sustained double-digit growth. He noted Linde is being more selective on memory projects because of their shorter cycles, preferring long-term contracts, and is focused on logic. Chemicals and Energy rose 12%, helped by U.S. Gulf Coast and Chinese customers benefiting from raw material advantages during the Middle East conflict, with complex refiners needing more hydrogen to process heavier, higher-sulfur crude. U.S. packaged gas growth remained in the low teens on construction and data centers, while rare gas sales for satellite propulsion softened as payloads await launch.

Europe remains the weak spot. Reported volume of +1% was, according to Lamba, flattered by equipment sales; underlying volume was flat, which is better than the declines of 2% to 3% a year or 18 months ago. His outlook was blunt: "There is 0 catalyst." He cited European power at EUR 150 per megawatt hour and natural gas at EUR 30 per MMBtu, and criticized the lack of consistent policy. "I would not hold my breath for the medium term." The Nordics are an exception thanks to cheap hydropower. In China, steel production fell 2.5% on government curtailments, while electronics industrial production rose about 17%. Lamba expressed concern about weak domestic demand, noting domestic EV purchases down 11% to 12%, and said export strength is unlikely to last.

Backlog, Woodside and Helium

The sale of gas backlog is close to $8 billion, with roughly $1 billion of start-ups expected in the quarter, and management still targets the "8 handle" at year-end. The sale of plant backlog is just under $3 billion and includes some space-related work. On Woodside's Beaumont ammonia project, now under strategic review by the customer, the air separation unit started up in the third quarter, the two autothermal reformer trains should be completed in the first half of 2027, and carbon capture, handled by ExxonMobil, is the remaining item. Financial contribution begins in the second half of 2027, with full ramp likely in 2028. In the meantime, Linde is supplying the customer from its existing hydrogen network, molecules it could otherwise sell at attractive Gulf Coast prices. Lamba expressed confidence in the quality of the asset irrespective of its owner.

On helium, Linde has added customers on long-term contracts and built dislocation costs from the Middle East disruption into pricing, though margin gains are limited because those costs also sit in the cost base. Lamba said Linde has "not tried to use this opportunity to excessive pricing," mindful that helium will eventually be long. He expects Qatar to reach about 75% of production, with export logistics, not output, as the constraint, and said Linde moved about 340 containers last quarter from sources across the U.S., North Africa, Europe and Asia.

Capital Deployment

Operating cash flow rose 8% to $3.2 billion, with the second half seasonally stronger. Linde has deployed over $9 billion year-to-date, about half into the business and half returned to shareholders. White said rising interest rates reinforce that "balance sheets and cash flow matter."